Abstract
Backgrounds/Aims
Methods
Results
REFERENCES
Table 1
Variable | Number |
---|---|
Preoperative laboratory parameter | |
Platelet count, ×104/mL | 20.2 ± 8.1 |
Prothrombin activity, % (n = 177) | 92.9 ± 17.9 |
Albumin, g/dL | 3.89 ± 0.41 |
Prealbumin, g/dL (n = 98) | 21.8 ± 6.4 |
Total bilirubin, mg/dL | 0.80 ± 0.46 |
Total cholesterol, mg/dL (n = 175) | 179 ± 49 |
PNI | 39.6 ± 5.1 |
PNI < 40 | 91 (50.0) |
White blood cells, per mm3 | 555 ± 1,746 |
Lymphocyte counts, per mm3 | 1,571 ± 597 |
Lymphocyte ratio of the blood, % | 29.4 ± 9.8 |
Functional liver parameter | |
Indocyanine green retention rate at 15 min, % | 11.7 ± 7.5 |
LHL15, % | 92.2 ± 3.5 |
Serum hyaluronic acid, ng/mL (n = 154) | 100.1 ± 114.7 |
Surgical record | |
Blood loss, mL | 886 ± 1,270 |
Transfusion, mL | 302 ± 810 |
Transfusion, yes | 37 (20.3) |
Operation time (min) | 397 ± 188 |
Transection time (min)a) | 43.4 ± 37.4 |
Postoperative impaired liver functional parameterb) | |
Total bilirubin, mg/dL | 1.85 ± 1.44 |
Alanine aminotransferase, IU/L | 329 ± 257 |
Prothrombin activity, % | 63.1 ± 12.1 |
Platelet counts, per mm3 | 13.4 ± 8.1 |
C-reactive protein, mg/dL | 11.2 ± 5.0 |
Postoperative adverse events and outcome | |
In-hospital mortality, yes/no | 1 (0.5)/181 |
Total morbidity, yes/no | 45 (24.7)/137 |
Hepatectomy-related complications, yes/no | 28 (15.4)/154 |
Hepatic failure, yes/no | 4 (2.2)/178 |
Intra-abdominal infection, yes/no | 13 (7.1)/169 |
Uncontrolled ascites, yes/no | 13 (7.1)/169 |
Bile leakage, yes/no | 16 (8.8)/166 |
Hospital stay (day) | 18.5 ± 19.2 |
PNI, Onodera et al. [4]’s Prognostic Nutritional Index; LHL15, liver uptake ratio of 99m-technetium galactosyl serum albumin scintigraphy between 3 and 15 minutes.
Table 2
Nutritional parameter | Albumin | Prealbumin | Total cholesterol | LN rate | LN counts | PNI |
---|---|---|---|---|---|---|
Albumin (g/dL) | - | 0.577** | 0.125 | 0.128 | 0.255** | 0.997** |
Prealbumin | 0.577** | - | 0.124 | 0.224* | 0.232* | 0.582** |
Total cholesterol (mg/dL) | 0.125 | 0.124 | - | –0.092 | 0.232* | 0.182* |
LN rate (%) | 0.128 | 0.224* | –0.092 | - | 0.648** | 0.120 |
LN counts (per mm3) | 0.255** | 0.232* | –0.023 | 0.648** | - | 0.251** |
PNI | 0.997** | 0.582** | 0.182* | 0.120 | 0.251** | - |
LN, lymphocyte; PNI, Onodera et al. [4]’s Prognostic Nutritional Index; -, not available.
Table 3
Variable | Albumin | Prealbumin | TC | LN% | LNC | PNI | PNI < 40/≥ 40a) |
---|---|---|---|---|---|---|---|
Age | –0.243** | –0.218* | –0.106 | –0.013 | –0.152* | –0.249** | 68.5 ± 9.1/ |
Sex | 63.9 ±10.9** | ||||||
Male (n = 127) | 4.0 ± 0.4 | 22.9 ± 5.6 | 179 ± 39 | 29 ± 10 | 1569 ± 566 | 40.0 ± 5.5 | 57/70 (56) |
Female (n = 55) | 3.8 ± 0.4* | 20.0 ± 7.3 | 199 ± 63** | 31 ± 11 | 1578 ± 668 | 38.9 ± 4.1 | 34/21 (48) |
Disease | |||||||
HCC (n = 90) | 3.9 ± 0.4 | 19.8 ± 5.7 | 165 ± 31 | 31 ± 10 | 1645 ± 654 | 39.6 ± 6.0 | 47/43 |
ICC (n = 12) | 3.8 ± 0.4 | 23.9 ± 5.2 | 177 ± 34 | 29 ± 10 | 1532 ± 510 | 38.6 ± 3.5 | 8/4 |
Liver metastasis (n = 46) | 3.9 ± 0.4 | 23.5 ± 5.4 | 199 ± 64 | 27 ± 9 | 1554 ± 494 | 39.8 ± 4.5 | 20/26 |
ECC (n = 12) | 3.7 ± 0.4 | 17.2 ± 5.3 | 197 ± 94 | 25 ± 13 | 1298 ± 680 | 38.2 ± 4.0 | 8/4 |
GBC (n = 16) | 4.0 ± 0.4 | 25.8 ± 8.0 | 187 ± 26 | 28 ± 10 | 1382 ± 384 | 40.4 ± 3.5 | 7/9 |
Other (n = 6) | 4.0 ± 0.4 | 22.8 ± 10.5 | 186 ± 31 | 29 ± 10 | 1664 ± 774 | 41.5 ± 4.9 | 1/5 |
Liver functional parameter | - | ||||||
ICGR15 | –0.296** | –0.335** | –0.203** | 0.181* | –0.078 | –0.339** | |
LHL15 | 0.184** | 0.204* | –0.226** | –0.225** | –0.020 | 0.197** | |
Prothrombin activity (%) | 0.133 | 0.213* | 0.305** | –0.009 | 0.068 | 0.159* | |
Total bilirubin (mg/dL) | 0.090 | 0.090 | 0.037 | 0.043 | –0.100 | 0.093 | |
Hyaluronic acid (ng/mL) | –0.340** | 0.212* | –0.088 | 0.086 | –0.080 | –0.399** | |
Surgical record | |||||||
Extent of hepatectomy | |||||||
Major (n = 31) | 3.7 ± 0.4 | 18.9 ± 6.7 | 188 ± 74 | 26 ± 11 | 1429 ± 562 | 38.0 ± 4.0 | 30/12 |
Minor (n = 143) | 4.0 ± 0.4 | 22.6 ± 6.2 | 176 ± 38 | 31 ± 9 | 1620 ± 607 | 40.2 ± 5.4 | 58/78 |
Transection time | 0.085 | –0.162 | 0.010 | 0.021 | 0.027 | 0.092 | - |
Operation time (min) | –0.139 | –0.171 | 0.159 | –0.204 | –0.085 | –0.057 | - |
Blood loss (mL) | –0.122 | –0.080 | 0.026 | –0.120 | –0.172* | –0.097 | - |
Transfusion | –0.091 | –0.068 | 0.024 | –0.127 | –0.170* | –0.085 | - |
No | 3.9 ± 0.4 | 22.3 ± 6.3 | 177 ± 43 | 31 ± 10 | 1644 ± 604 | 40.2 ± 4.0 | |
Yes (n = 37) | 3.8 ± 0.5* | 19.7 ± 6.5 | 189 ± 68 | 26 ± 10* | 1329 ± 540** | 37.6 ± 7.9 | |
Postoperative functionb) | - | ||||||
Total bilirubin | –0.055 | –0.003 | –0.063 | 0.083 | –0.028 | –0.026 | |
Alanine aminotransferase | 0.013 | 0.043 | 0.077 | –0.125 | 0.041 | 0.032 | |
Prothrombin activity | 0.133 | 0.277** | 0.178* | –0.024 | –0.015 | –0.014 | |
Platelet | 0.056 | 0.119 | 0.087 | –0.130 | –0.069 | 0.057 | |
C-reactive protein | 0.020 | –0.007 | 0.083 | –0.061 | 0.090 | 0.032 | |
Postoperative coarse | |||||||
Total complication | |||||||
No | 4.0 ± 0.4 | 22.9 ± 6.3 | 177 ± 40 | 31 ± 9 | 1,612 ± 545 | 40.1 ± 5.4 | 59/72 (55) |
Yes (n = 45) | 3.8 ± 0.4** | 19.1 ± 6.2** | 187 ± 68 | 28 ± 12 | 1,480 ± 740 | 38.5 ± 4.2* | 28/17 (38) |
HT-related complication | |||||||
No | 4.0 ± 0.4 | 22.7 ± 6.3 | 177 ± 39 | 30 ± 10 | 1,597 ± 606 | 40.1 ± 5.3 | 66/82 (75) |
Yes (n = 28) | 3.7 ± 0.4** | 17.4 ± 4.8** | 189 ± 84 | 27 ± 10 | 1,482 ± 581 | 37.7 ± 4.0** | 21/7 (46)** |
Liver failure | |||||||
No | 3.9 ± 0.4 | 21.9 ± 6.4 | 180 ± 49 | 30 ± 10 | 1,590 ± 600 | 39.4 ± 5.3 | 84/88 |
Yes (n = 4) | 3.7 ± 0.3 | 18.5 ± 6.8 | 148 ± 37 | 24 ± 6 | 1,063 ± 490 | 38.9 ± 6.0 | 3/1 |
Intra-abdominal infection | |||||||
No | 3.9 ± 0.4 | 22.0 ± 6.5 | 178 ± 46 | 30 ± 10 | 1,589 ± 596 | 39.8 ± 5.2 | 79/84 |
Yes (n = 13) | 3.8 ± 0.4 | 19.4±5.5 | 197 ± 75 | 30 ± 12 | 1,452 ± 686 | 38.7 ± 4.3 | 8/5 |
Ascites | |||||||
No | 3.9 ± 0.4 | 21.8 ± 6.6 | 180 ± 50 | 30 ± 10 | 1,567 ± 606 | 39.7 ± 5.2 | 78/85 |
Yes (n = 13) | 3.8 ± 0.4 | 20.8 ± 1.4 | 164 ± 33 | 29 ± 13 | 1,718 ± 548 | 38.9 ± 3.8 | 9/4 |
Bile leak | |||||||
No | 3.9 ± 0.4 | 22.4 ± 6.2 | 175 ± 39 | 30 ± 10 | 1,598 ± 597 | 39.9 ± 5.2 | 76/84 |
Yes (n = 16) | 3.6 ± 0.5* | 16.7 ± 6.0* | 215 ± 99 | 24 ± 11 | 1,386 ± 636 | 37.5 ± 4.4* | 11/5 |
Hospital stay (day) | –0.194* | –0.267** | –0.098 | –0.131 | –0.123 | –0.155* |
Values are presented as the mean ± standard deviation. Correlation was indicated as r by Pearson co-efficiency test. Categorical data were examined by chi-squared test. Major hepatectomy included hemihepatectomy or more extended hepatectomy, minor included others.
PNI, Onodera et al. [4]’s Prognostic Nutritional Index; TC, total cholesterol; LN%, lymphocyte rate; LNC, lymphocyte counts; HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; ECC, extrahepatic cholangiocarcinoma; GBC, gall bladder carcinoma; ICGR15, indocyanine green retention rate at 15 minutes; LHL15, liver uptake ratio of 99m-technetium galactosyl serum albumin scintigraphy between 3 and 15 minutes; HT, hepatectomy; -, not available.
Table 4
Model | Non-standardization factor | Standardization coefficient | t-value | Significance probability (p-value) | Risk ratio | 95% confidence interval | |||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
B | SE | β | Lower-limit | Upper-limit | |||||
Total postoperative complications | |||||||||
(Constant) | 0.212 | 0.073 | - | 2.894 | 0.005* | - | 0.066 | 0.358 | |
Age | –0.069 | 0.122 | –0.076 | –0.569 | 0.571 | 0.93 | –0.312 | 0.174 | |
Prealbumin | –0.015 | 0.139 | –0.015 | –0.105 | 0.917 | 0.99 | –0.293 | 0.264 | |
Albumin | 0.288 | 0.130 | 0.297 | 2.208 | 0.031* | 1.33 | 0.028 | 0.548 | |
ICGR15 | –0.008 | 0.219 | –0.006 | –0.036 | 0.971 | 0.99 | –0.445 | 0.429 | |
LHL15 | –0.055 | 0.213 | –0.047 | –0.256 | 0.799 | 0.95 | –0.480 | 0.370 | |
Prothrombin activity | 0.181 | 0.276 | 0.082 | 0.658 | 0.513 | 1.20 | –0.369 | 0.732 | |
Hyaluronic acid | 0.231 | 0.227 | 0.132 | 1.017 | 0.313 | 1.26 | –0.222 | 0.684 | |
Hepatectomy related postoperative complications | |||||||||
(Constant) | 0.120 | 0.056 | - | 2.131 | 0.037* | - | 0.008 | 0.232 | |
Age | –0.030 | 0.094 | –0.041 | –0.316 | 0.753 | 0.97 | –0.217 | 0.157 | |
Prealbumin | –0.046 | 0.107 | –0.059 | –0.433 | 0.666 | 0.96 | –0.261 | 0.168 | |
Albumin | 0.245 | 0.100 | 0.324 | 2.443 | 0.017* | 1.28 | 0.045 | 0.445 | |
ICGR15 | –0.014 | 0.169 | –0.015 | –0.083 | 0.934 | 0.99 | –0.350 | 0.323 | |
LHL15 | –0.060 | 0.164 | –0.067 | –0.368 | 0.714 | 0.94 | –0.387 | 0.267 | |
Prothrombin activity | –0.110 | 0.109 | –0.143 | –1.006 | 0.318 | 0.90 | –0.328 | 0.108 | |
Hyaluronic acid | –0.053 | 0.212 | –0.031 | –0.252 | 0.802 | 0.95 | –0.477 | 0.370 | |
Bile leakage | |||||||||
(Constant) | 0.032 | 0.041 | - | 0.788 | 0.433 | - | –0.049 | 0.114 | |
Age | –0.087 | 0.067 | –0.139 | –1.300 | 0.197 | 0.92 | –0.220 | 0.046 | |
Prealbumin | 0.136 | 0.079 | 0.196 | 1.727 | 0.087 | 1.15 | –0.020 | 0.293 | |
Albumin | 0.092 | 0.075 | 0.139 | 1.226 | 0.223 | 1.10 | –0.057 | 0.240 | |
Lymphatic counts | 0.171 | 0.071 | 0.239 | 2.422 | 0.017* | 1.19 | 0.031 | 0.312 |